Bleichroeder LP 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:17 am Purchase | 2025-06-30 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | Bleichroeder LP | 666,667 8.030% | 666,667 (New Position) | Filing |